Drx Choice Fiber Therapy Powder, For Solution
Product Images NDC 68163-517

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Drx Choice Fiber Therapy (NDC 68163-517). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Raritan Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Drx Choice Fiber Therepy Methycellulose (5b594fa0 45d9 4676 A082 7cf767cf30a1 06)

Drx Choice  Fiber Therepy Methycellulose (5b594fa0 45d9 4676 A082 7cf767cf30a1 06)
This is a description of Citrucel Powder's active ingredient. The tamper-evident container should not be used if the inner seal is broken or missing. The drug facts indicate abdominal pain, vomiting, or persistent constipation as potential side effects. The product must be mixed with a full glass of water or fluid to avoid choking. The use of this product is not recommended without consulting a physician if you have difficulty in swallowing or have chest pain after taking it. The inactive components, temperature recommendations, and contact data are also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.